TDOC
NYSETELADOC HEALTH, INC.
Healthcare · Services-Offices & Clinics Of Doctors Of Medicine
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
🔒 price chart needs market-data feed$2.0B
2021
$2.4B
2022
$2.6B
2023
$2.6B
2024
$2.5B
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$2.5B
Net Income$-200.3M
Gross Profit—
Oper Income$-263.0M
EPS (dil)$-1.14
Rev/sh$14.02
FCF/sh$1.58
Book/sh$7.68
Gross M—
Oper M-10.4%
Profit M-7.9%
FCF M11.3%
ROE-14.5%
ROA-7.0%
ROIC-34.5%
R&D/Rev11.0%
Rev Y/Y-1.5%
Rev 3Y CAGR1.7%
EPS Y/Y80.6%
EPS 3Y CAGR—
FCF 3Y CAGR18.2%
Payout—
Div/sh—
Shs Chg Y/Y+3.3%
Current Ratio2.77
Quick Ratio2.67
Debt/Eq0.03
Int Coverage-13.3×
Net Debt$738.6M cash
Total Debt$42.4M
Cash & Eq$781.1M
Total Assets$2.9B
Oper CF$294.4M
Capex$8.9M
Free CF$285.5M
Buybacks$368,000
Equity$1.4B
Liabilities$1.5B
Shs Outstand0.18B
SectorHealthcare
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.0B | $2.4B | $2.6B | $2.6B | $2.5B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $-265.6M | $-13.7B | $-248.6M | $-1.0B | $-263.0M |
| Net Income | $-428.8M | $-13.7B | $-220.4M | $-1.0B | $-200.3M |
| Diluted EPS | $-2.73 | $-84.60 | $-1.34 | $-5.87 | $-1.14 |
| Operating Cash Flow | $194.0M | $189.3M | $350.0M | $293.7M | $294.4M |
| Free Cash Flow | $185.5M | $172.8M | $338.6M | $282.9M | $285.5M |
COMMUNITY · $TDOC0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.